Why Emergent BioSolutions Stock Blasted Higher Today
An analyst initiated coverage of Emergent BioSolutions (NYSE: EBS) stock as the last trading week of 2024 kicked off, and investors reacted quite positively to the move. On the news, they piled into the...
Why Emergent BioSciences Stock Plummeted Today
Emergent BioSolutions (NYSE: EBS) saw its shares tumble on Tuesday, due to news of a share sell-off. The vaccine maker divulged in a regulatory filing that several institutional share and warrant holders...
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week
As the new week unfolds, earnings and economic data will again dictate sentiment.
Emergent Biosolutions Stock Soars After Q3 Earnings: Retail Sentiment Strong
Earnings per share for Q3 came in at $1.37, compared to consensus estimates of $0.10.
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
EBS earnings call for the period ending September 30, 2024.